The latest programme aimed at using highly personalised treatment for cancer patients is launched today.
Some 250 patients with breast cancer in Cambridge, UK, will take part in the project, which will see them undergoing detailed genetic analysis as part of their treatment.
Researchers say the analysis will mean patients can be assigned to the best treatment.
Professor Richard Gilbertson, of Cambridge University, said it would change breast cancer treatment "forever."
The researchers are building on an earlier finding that there are 20 different kinds of breast cancer.
Professor Carlos Caldas, who is leading the project, said: “We already know that there are around 10 different types of breast cancer, as we reported in 2012, and these respond differently to the available treatments. We’re looking at ways to predict this response ensuring individual patients get the best treatment for them.
"We hope that this project will accelerate progress in developing personalised treatment for breast cancer patients.”
Leave a Reply